Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Andrew S. Hunter PharmD"'
Autor:
Ryan Geffin MD, Shazia Raheem PharmD, Lavannya M. Pandit MD, MS, Andrew S. Hunter PharmD, Michael W. Holliday MD, PhD, Aditya V. Rao, Maulin K. Shah MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 11 (2023)
End-stage kidney disease (ESKD) has been shown to be correlated with an increased risk of COVID-19 infection and mortality. Remdesivir is an effective non-EUA U.S. Food and Drug Administration (FDA)-approved antiviral agent for the treatment of COVID
Externí odkaz:
https://doaj.org/article/246067835b924340a7d4331fb62b66e6
